Animated publication summary

Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial

Author
Ettingshausen CE, Hegemann I, Simpson ML, Cuker A, Kulkarni R, Pruthi RK, Garly ML, Meldgaard RM, Persson, P Klamroth R,
Citation

Escuriola Ettingshausen C, Hegemann I, Simpson ML, et al. Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX-Fc fusion protein: A randomized trial. Res Pract Thromb Haemost<7em>. 2019;3(2):268–276.

Date of Publication

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com